Tolero Pharmaceuticals and AbbVie partner to develop AML therapy
Biopharmaceutical firm Tolero Pharmaceuticals and AbbVie have formed a clinical research alliance to evaluate venetoclax...
Agios’ Tibsovo gains FDA approval as targeted AML treatment
The US Food and Drug Administration (FDA) has granted approval for Agios Pharmaceuticals Tibsovo (ivosidenib)...